News
January 24, 2020
Tazverik™ (tazemetostat)
Epizyme has chosen Onco360 as the exclusive partner for TAZVERIK™ (tazemetostat), a new oral treatment for adult and pediatric patients (aged 16 years and older) with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.
August 16, 2019
Now Dispensing INREBIC®
Onco360 is privileged to be selected as a specialty pharmacy provider for INREBIC®.
July 30, 2019
Dispensing NUBEQA®
NUBEQA® is available now through Onco360 Oncology Specialty Pharmacy.
July 11, 2019
Inclement Weather Alert
The impact of the budding hurricane, Tropical Storm Barry, on the Gulf of Mexico region is expected to be significant and may affect our pharmacy operations and delivery in limited areas.
July 3, 2019
Now Dispensing XPOVIO™
Onco360 is selected as 1 of 3 specialty pharmacies to dispense XPOVIO™ (selinexor).
June 5, 2019
Ron Bookman Scholarship Announced
The National Association of Specialty Pharmacy (NASP) has announced a scholarship program created in memory of our friend and colleague, Ron Bookman.
March 10, 2019
In Loving Memory
It is with great sadness that we announce the passing of our friend and colleague, Ron Bookman, on March 5, 2019.
November 30, 2018
Selected to Dispense XOSPATA
Onco360 was selected as 1 of only 3 Specialty Pharmacy providers to dispense XOSPATA® (Gilteritinib) for the treatment of patients with relapsed or refractory FMS-like Tyrosine Kinase 3 (FLT3) mutation-positive acute myeloid leukemia (AML).
November 1, 2018
Dispensing Talzenna + Vizimpro
Talzenna® and Vizimpro® available now through Onco360 Oncology Specialty Pharmacy.